mk-677 vs cjc-1295 ipamorelin for muscle growth Peptide Therapy Alternatives MAXIMIZE Growth Hormone With Ipamorelin

For targeted abdominal or visceral fat support, Tesamorelin has evidence in HIV-associated lipodystrophy, but it is not FDA-approved as a general weight-loss drug

HGH itself requires specific medical diagnoses

Gut health: BPC-157 specifically supports gut lining repair, with digestive health improvements often reported concurrently with the tissue repair timeline

Fat lost stays off with appropriate nutrition

The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis